English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [913]
News [2608]
Articles [111]
Editorials [3]
Conferences [85]
elearning [27]
New afatinib data suggests hope for non-small-cell lung adenocarcinoma patients with EGFR mutations
New afatinib data suggests hope for non-small-cell lung adenocarcinoma patients with EGFR mutations
Pancreatic cancer predicted to overtake other cancer-related deaths in the USA by 2030
Pancreatic cancer predicted to overtake other cancer-related deaths in the USA by 2030
Pancreatic cancer projected to become second leading cause of cancer-related death in the United States by 2030
Pancreatic cancer projected to become second leading cause of cancer-related death in the United States by 2030
Research in several cancers reveals promising treatment strategies, new insights on screening, and obesity-cancer link
Research in several cancers reveals promising treatment strategies, new insights on screening, and obesity-cancer...
New EGFR inhibitor AZD9291 shows promising activity in treatment-resistant non-small cell lung cancer
New EGFR inhibitor AZD9291 shows promising activity in treatment-resistant non-small cell lung cancer
Study projects nationwide LDCT screening will identify more – and earlier-stage – lung cancers, but comes with substantial medicare costs
Study projects nationwide LDCT screening will identify more – and earlier-stage – lung cancers, but comes with...
Asprin could combat permanent hearing loss caused by cancer drug
Asprin could combat permanent hearing loss caused by cancer drug
Poor quality of life doesn’t predict low survival rates in high-risk lung cancer patients undergoing surgery
Poor quality of life doesn’t predict low survival rates in high-risk lung cancer patients undergoing surgery
Half of all UK cancer patients now survive at least 10 years
Half of all UK cancer patients now survive at least 10 years
AACR urges FDA regulation of all tobacco products, including e-cigarettes
AACR urges FDA regulation of all tobacco products, including e-cigarettes
<1...198199200201202...261>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top